Heparin-Bonded Stent-Graft for the Treatment of TASC II C and D Femoropopliteal Lesions: 36-Month Results of the Viabahn 25 cm Trial.

Tanja BöhmeElias NooryKlaus BrechtelDierk ScheinertMarc BosiersUlrich BeschornerThomas Zeller

Published in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2020)

The primary patency rate without reintervention after treatment of long femoropopliteal lesions is low. However, secondary patency after implantation of a Viabahn endoprosthesis is high and seems to be superior to the use of other revascularization techniques, resulting in persistent clinical improvement.

Keyphrases

clinical trial
study protocol
percutaneous coronary intervention
phase ii
combination therapy
atrial fibrillation
endovascular treatment